0 CHECKOUT

Adamis Pharmaceuticals Corporation - Product Pipeline Review - 2015

  • ID: 3384932
  • July 2015
  • 38 pages
  • Global Markets Direct
1 of 3

Adamis Pharmaceuticals Corporation - Product Pipeline Review - 2015

Summary

The report ‘Adamis Pharmaceuticals Corporation - Product Pipeline Review - 2015’, provides an overview of the Adamis Pharmaceuticals Corporation’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Adamis Pharmaceuticals Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic READ MORE >

Note: Product cover images may vary from those shown
2 of 3

List of Tables
List of Figures
Adamis Pharmaceuticals Corporation Snapshot
Adamis Pharmaceuticals Corporation Overview
Key Information
Key Facts
Adamis Pharmaceuticals Corporation - Research and Development Overview
Key Therapeutic Areas
Adamis Pharmaceuticals Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Adamis Pharmaceuticals Corporation - Pipeline Products Glance
Adamis Pharmaceuticals Corporation - Late Stage Pipeline Products
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Adamis Pharmaceuticals Corporation - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Adamis Pharmaceuticals Corporation - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Adamis Pharmaceuticals Corporation - Drug Profiles
epinephrine
Product Description
Mechanism of Action
R&D Progress
(fluticasone propionate + salmeterol xinafoate)
Product Description
Mechanism of Action
R&D Progress
APC-3000
Product Description
Mechanism of Action
R&D Progress
beclomethasone dipropionate
Product Description
Mechanism of Action
R&D Progress
APC-100
Product Description
Mechanism of Action
R&D Progress
TeloB-VAX
Product Description
Mechanism of Action
R&D Progress
APC-200
Product Description
Mechanism of Action
R&D Progress
APC-300
Product Description
Mechanism of Action
R&D Progress
C-31G
Product Description
Mechanism of Action
R&D Progress
Adamis Pharmaceuticals Corporation - Pipeline Analysis
Adamis Pharmaceuticals Corporation - Pipeline Products by Target
Adamis Pharmaceuticals Corporation - Pipeline Products by Route of Administration
Adamis Pharmaceuticals Corporation - Pipeline Products by Molecule Type
Adamis Pharmaceuticals Corporation - Pipeline Products by Mechanism of Action
Adamis Pharmaceuticals Corporation - Recent Pipeline Updates
Adamis Pharmaceuticals Corporation - Dormant Projects
Adamis Pharmaceuticals Corporation - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
C-31G
Adamis Pharmaceuticals Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Adamis Pharmaceuticals Corporation, Key Information
Adamis Pharmaceuticals Corporation, Key Facts
Adamis Pharmaceuticals Corporation - Pipeline by Indication, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Stage of Development, 2015
Adamis Pharmaceuticals Corporation - Monotherapy Products in Pipeline, 2015
Adamis Pharmaceuticals Corporation - Combination Treatment Modalities in Pipeline, 2015
Adamis Pharmaceuticals Corporation - Filing rejected/Withdrawn, 2015
Adamis Pharmaceuticals Corporation - Phase II, 2015
Adamis Pharmaceuticals Corporation - Phase I, 2015
Adamis Pharmaceuticals Corporation - Preclinical, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Target, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Route of Administration, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Molecule Type, 2015
Adamis Pharmaceuticals Corporation - Pipeline Products by Mechanism of Action, 2015
Adamis Pharmaceuticals Corporation - Recent Pipeline Updates, 2015
Adamis Pharmaceuticals Corporation - Dormant Developmental Projects,2015
Adamis Pharmaceuticals Corporation - Discontinued Pipeline Products, 2015
Adamis Pharmaceuticals Corporation, Subsidiaries

List of Figures
Adamis Pharmaceuticals Corporation - Pipeline by Top 10 Indication, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Stage of Development, 2015
Adamis Pharmaceuticals Corporation - Monotherapy Products in Pipeline, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Top 10 Target, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Top 10 Route of Administration, 2015
Adamis Pharmaceuticals Corporation - Pipeline by Top 10 Molecule Type, 2015
Adamis Pharmaceuticals Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.